Source: Vaccines. Unidades: ICB, BIOTECNOLOGIA
Subjects: MICROBIOLOGIA, POLIMORFISMO, CITOMEGALOVIRUS, IMUNOGLOBULINAS, SURTOS DE DOENÇAS, COVID-19, INTERFERONS, IDOSOS
ABNT
NARDY, Ariane et al. Assessment of the interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV. Vaccines, v. 11, n. 2, p. 1-18, 2023Tradução . . Disponível em: https://doi.org/10.3390/vaccines11020480. Acesso em: 14 out. 2024.APA
Nardy, A., Camargo, C. T. S., Oliveira, Y. F. C. de, Silva, F. C. da, Almeida, M. S. de, Monteiro, F. R., et al. (2023). Assessment of the interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV. Vaccines, 11( 2), 1-18. doi:10.3390/vaccines11020480NLM
Nardy A, Camargo CTS, Oliveira YFC de, Silva FC da, Almeida MS de, Monteiro FR, Silva BR, Amaral JB do, Oliveira DBL de, Durigon EL, Scagion GP, Chalup VN, Candido ÉD, Aguiar AS, Novo NF, Shio MT, França CN, Nali LH da S, Bachi ALL. Assessment of the interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV [Internet]. Vaccines. 2023 ; 11( 2): 1-18.[citado 2024 out. 14 ] Available from: https://doi.org/10.3390/vaccines11020480Vancouver
Nardy A, Camargo CTS, Oliveira YFC de, Silva FC da, Almeida MS de, Monteiro FR, Silva BR, Amaral JB do, Oliveira DBL de, Durigon EL, Scagion GP, Chalup VN, Candido ÉD, Aguiar AS, Novo NF, Shio MT, França CN, Nali LH da S, Bachi ALL. Assessment of the interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV [Internet]. Vaccines. 2023 ; 11( 2): 1-18.[citado 2024 out. 14 ] Available from: https://doi.org/10.3390/vaccines11020480